Requirements for Medical Testing of Human Nucleic Acids, 2nd Edition - Draft for Consultation

Reference List

A draft document, provided by the National Pathology Accreditation Advisory Council, for public consultation of updated requirements for the medical testing of nucleic acids.

Page last updated: 22 October 2012

1. NPAAC (National Pathology Accreditation Advisory Council) (2011) Requirements for Medical Testing of Microbial Nucleic Acids, Australian Government Department of Health and Ageing, Canberra.

2. NPAAC (National Pathology Accreditation Advisory Council) (2007) Requirements for Cytogenetic Testing, Australian Government Department of Health and Ageing, Canberra.

3. AS ISO 15189 – 2009 Medical Laboratories – Particular requirements for quality and competence, Standards Australia

4. AS ISO 15189 NATA Field Application Document: Medical Testing – Supplementary requirements for Accreditation, National Association of Testing Authorities, Australia.

5. ISO 13485 Medical Devices – Quality Management Systems – Requirements for Regulatory Purposes, International Organization for Standardization, Geneva.

6. ISO 14971 Medical Devices – Application of Risk Management to Medical Devices, International Organization for Standardization, Geneva.

7. NPAAC (National Pathology Accreditation Advisory Council) (2007) Requirements for the Development and Use of In-House In-Vitro Diagnostic Devices (IVDs), Australian Government Department of Health and Ageing, Canberra.

8. NHMRC (National Health and Medical Research Council) (2010). Medical Genetic Testing: Information for health professionals. Australian Health Ethics Committee, NHMRC. Accessed at <http://www.nhmrc.gov.au/publications/synopses/e99syn.htm> in January 2011.

9. ALRC–NHMRC (Australian Law Reform Commission and National Health and Medical Research Council) (2003). Essentially Yours – The Protection of Human Genetic Information in Australia, ALRC. Accessed at <http://www.austlii.edu.au/au/other/alrc/publications/reports/96/> in January 2011.

10. Burnett L, Barlow-Stewart K, Proos A and Aizenberg H (2003). The “GeneTrustee”: a universal identification system that ensures privacy and confidentiality for human genetic databases. Journal of Law and Medicine 10: 506-13.

11. RCPA (2007). Sample requirements for medical genetic testing: Do genetic tests demand a different standard? Position Statement 3/2007 of the Royal College of Pathologists of Australasia, Surry Hills NSW. Accessed at http://www.rcpa.edu.au/static/File/Asset library/public documents/Policy Manual/Position Statements/Sample requirements for medical genetic testing.pdf in January 2010.

12. NPAAC (National Pathology Accreditation Advisory Council) (2007) Requirements for the Packaging and Transport of Pathology Specimens and Associated Materials, Australian Government Department of Health and Ageing, Canberra.

13. Shapiro DS (1999). Quality control in nucleic acid amplification methods: use of elementary probability theory. Journal of Clinical Microbiology 37:848–851.

14. Swiss Society of Medical Genetics (2003). Best practice guidelines on reporting in molecular genetic diagnostic laboratories in Switzerland, Version 1. Accessed at http://www.sgmg.ch/view_page_professional.php?view=page&page_id=19 in September 2008.

15. OECD (2007). OECD Guidelines for Quality Assurance in Molecular Genetic Testing. Accessed at www.oecd.org/document/24/0,3343,en_2649_34537_1885208_1_1_1_1,00.html in September 2008.

16. NCCLS (2000). Molecular Diagnostic Methods for Genetic Diseases; Approved Guidelines. NCCLS Document MM1-A.

17. American College of Medical Genetics (2006). Standards and Guidelines for Clinical Genetics Laboratories. Accessed at http://www.acmg.net/Pages/ACMG_Activities/stds-2002/g.htm in September 2008.

18. Gulley ML, Braziel RM, Halling KC, Hsi ED, Kant JA, Nikiforova MN et al (2007). Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med 131:852-863.

19. RCPA (2009). Guidelines for reporting molecular genetic tests to medical practitioners. Guideline 1/2009 of the Royal College of Pathologists of Australasia, Surry Hills NSW. Accessed at http://www.rcpa.edu.au/static/File/Asset library/public documents/Policy Manual/Guidelines/Guidelines for reporting molecular genetic tests to medical practitioners.pdf in January 2010.

20. den Dunnen JT, Antonarakis SE (2001). Nomenclature for the description of human sequence variations. Hum Genet. 109:121-4.

21. S. Karger, Basel (2009) ISCN (2009): An International System for Human Cytogenetic Nomenclature L.G.Shaffer, M.L.Slovak, L.J.Campbell (eds)

22. CMGS (2007). Practice guidelines for the Interpretation and Reporting of Unclassified Variants (UVs) in Clinical Molecular Genetics (draft). Guidelines ratified by the UK Clinical Molecular Genetics Society and the Dutch Society of Clinical Genetic Laboratory Specialists (Vereniging Klinisch Genetische Laboratoriumspecialisten. Accessed at cmgsweb.shared.hosting.zen.co.uk/BPGs/best_practice_guidelines.htm in September 2008.

23. Grist S, Dubowsky A, Suthers G (2008). Evaluating DNA sequence variants of unknown biological significance. In, Clinical Bioinformatics ed R Trent, Humana Press. ISBN: 978-1-58829-791-4

24. NPAAC (National Pathology Accreditation Advisory Council) (2007) Requirements for Pathology Laboratories, Australian Government Department of Health and Ageing, Canberra.

25. Powsner SM, Costa J, Homer RJ (2000). Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med 124:1040-6.

26. Dzik WH, Murphy MF, Andreu G, Heddle N, Hogman C, Kekomaki R, Murphy S, Shimizu M, Smit-Sibinga (2003). An international study of the performance of sample collection from patients. Vox Sanguis 85:40-7..

27. Murphy MF, Stearn BE, Dzik WH. Current performance of patient sample collection in the UK (2004). Transfus Med 14: 113-21.

28. Hofgartner WT, Tait JF. Frequency of problems during clinical molecular-genetic testing (1999). Am J Clin Pathol 112: 14-21.

Top of Page